INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm
30 avr. 2024 15h00 HE
|
Schall Law
The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, QuidelOrtho, Sharecare, and GoodRx and Encourages Investors to Contact the Firm
28 avr. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 28, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
GOODRX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc. and Encourages Investors to Contact the Firm
23 avr. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against GoodRx...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm
23 avr. 2024 16h27 HE
|
Schall Law
The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm
Former CEO of OptimizeRx to Put Millions of Dollars in Prescription Savings Right Into the Hands of Those Americans Looking for Relief
08 sept. 2022 08h46 HE
|
TranspareRx Corporation
NAPLES, Fla., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Former OptimizeRx CEO and founder David Harrell today announced the launch of his newest endeavor, TranspareRx. The company aims to bring full...
Bragar Eagel & Squire, P.C. Is Investigating TG Therapeutics, Allianz, GoodRx, and the WWE and Encourages Investors to Contact the Firm
15 juil. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against TG Therapeutics, Inc....
Bragar Eagel & Squire, P.C. Is Investigating Allianz, TrueBlue, and GoodRx and Encourages Investors to Contact the Firm
10 juil. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Allianz SE (OTCMKTS:...
Bragar Eagel & Squire, P.C. Is Investigating GoodRx, the WWE, Digital World, and Generac and Encourages Investors to Contact the Firm
04 juil. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, July 04, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc....
Bragar Eagel & Squire, P.C. Is Investigating TrueBlue, NeoGenomics, GoodRx, and Ebix and Encourages Investors to Contact the Firm
29 juin 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, June 29, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against TrueBlue, Inc. (NYSE:...
Bragar Eagel & Squire, P.C. Is Investigating GoodRx, Cassava, Ebix, and the WWE and Encourages Investors to Contact the Firm
24 juin 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc....